Navigation Links
Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
Date:3/18/2009

future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.


                               Transgenomic, Inc.
                             Summary Financial Results
                 Unaudited Condensed Consolidated Statements of Operations
                          (dollars in thousands except per share data)

                                     Three Months Ended      Year Ended
                                        December 31,         December 31,
                                      2008       2007       2008       2007
                                      ----       ----       ----       ----

    NET SALES                        $6,126      $6,531    $23,993    $23,176
    COST OF GOODS SOLD                2,776       2,610     10,345     10,483
      Gross profit                    3,350       3,921     13,648     12,693
    OPERATING EXPENSES:
      Selling, general and
       administrative                 1,972       2,748     10,795     11,466
      Research and development   
'/>"/>
SOURCE Transgenomic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Transgenomic, Inc. Forms Scientific Advisory Board
3. Transgenomic, Inc. Reports Third Quarter 2008 Results
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), a ... for patients, physicians, the biopharmaceutical industry, regulators, payers, ... signing of a three-year Research Collaboration Agreement (RCA) ... This initiative is designed to generate disruptive ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... trying to justify RFID investment wholly on the basis ... in their supply chain are merely deluding themselves. In ... these areas, it means that gross inefficiencies exist in ... improvements even without applying RFID. , ,The benefits of ...
... Software is partnering with Brooktrout Technology to ... , ,The addition of Brooktrout TR1034 intelligent fax boards to ... integrate real-time fax over IP with their VoIP networks, allowing ... and migrate to an IP-based system in the future as ...
... Care , a not-for-profit network of healthcare services in ... NetScaler, Inc. , for a new high-performance network. ... usage and response time across its network of more ... care clinics, home health care services. , ,System architect ...
Cached Biology Technology:The key to finding RFID's ROI 2The key to finding RFID's ROI 3The key to finding RFID's ROI 4
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
(Date:4/17/2014)... the process whereby the genetic information of DNA ... proteins, which have numerous different functions in living ... intermediary during gene expression, by relating the genetic ... in manufacturing proteins. , By examining the ... in an organism at a given time, researchers ...
(Date:4/17/2014)... full of wild animals and plant life, but there,s ... churning away in the soil, decomposing organic matter and ... role these fungi play in ecological systems, their identities ... scientists has generated a genetic map of more than ... was published this week in the Proceedings of ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Rapid and accurate mRNA detection in plant tissues 2Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3
... gases such as CO 2 , which are now known to ... for a number of years. In contrast to the atmosphere, the ... higher. In the global carbon cycle the sea ab-sorbs a proportion ... into the at-mosphere again. About half of the anthropogenic emission ...
... tomography (PET) imaging, seeing is believing: Evaluating a ... typically involves visual interpretation of scans of cancer ... indexone that reflects the reduction of metabolic activity ... responses to first-line chemotherapy, according to a study ...
... Todays Answers, Tomorrows Questions taking place in London ... brings together policymakers, researchers and natural scientists with what ... research in the field of genomics - the Economic ... DNA, genes and chromosomes are often described as ...
Cached Biology News:New ETH Zurich article published in scientific journal 'Nature' 2Quantitative PET imaging finds early determination of effectiveness of cancer treatment 2From GM farm animals to embryonic stem cell research 2From GM farm animals to embryonic stem cell research 3
... The Finnpipette BioControl is a major ... A complete liquid handling system - ... interchangeable tip cone modules. All five ... cone modules fit one handle. The ...
Sulfadimethoxine (CH-2027)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
Biology Products: